CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
September 2019—Mesa Biotech launched its respiratory syncytial virus test, the company’s second point-of-care test on its polymerase chain reaction testing platform, the Accula System, at the AACC annual scientific meeting. The Accula Flu A/Flu B test received FDA clearance in 2018. Both tests are indicated for use with nasal swab collection.
The FDA-cleared, CLIA-waived Accula System comprises a portable, palm-sized dock and a disposable, assay-specific test cassette. The tests are distributed in the U.S. by Sekisui Diagnostics under the Silaris brand.
Pages: 1 2